2 min read
ASCO Annual Meeting
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...
1 min read
Clinical trials require meticulous planning and strategic guidance for success. In this case study, Veristat's expertise was instrumental in transforming a clinical-stage biotech company's maiden Phase I trial for an immuno-oncology antibody.
Initially brought in for protocol writing and study design, Veristat assumed an advisory role to provide strategic consulting and regulatory strategy expertise. Our comprehensive planning approach included thorough research, risk mitigation strategies, and an exploration of regulatory pathways. Data-driven decision-making, a living document roadmap, and a proven impact on the sponsor's next trial highlight the success of this partnership.
This case study provides valuable insights for sponsors entering the pre-planning phase of their clinical trials. It showcases how a wholistic planning approach and strategic guidance can help achieve success in a complex and evolving landscape.
Download the Case Study: Your path from lab to clinic starts here.
Learn more
Press Release: Veristat Acquires European Medical Writing Consultancy Scinopsis
Case study: Advancing a Therapy for Rare Cancers to Regulatory Submission
Blog: Streamline the Medical Writing Process for Simultaneous Submissions